LGALS3BP and type 1 diabetes mellitus: A recent targeted proteomics study on TEDDY plasma samples found that LGALS3BP levels rise about 6 months before seroconversion, followed by fluctuations thereafter45, suggesting it might serve as an early biomarker of immune activation in T1D.